tweenvest

H. Lundbeck A/S (CPSE: HLUN B)

Health Care · Pharmaceuticals · DK

Dkr62.15

+2.22% today · +42.8% 1Y

Public summary
A free snapshot of H. Lundbeck A/S, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

H. Lundbeck A/S (CPSE: HLUN B) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $8.99B.

Over the last twelve months the share price has gained 42.8%, trading between 35.30 and 62.85.

Tweenvest scores H. Lundbeck A/S across four factors: quality 79/100, value 45/100, growth 78/100, dividend 82/100. Its strongest factor is dividend.

HLUN B price history

Nov 21, 2025 · 44.18Weekly closes 37.46 – 62.15Nov 18, 2026 · 62.15

Key figures

Market cap
$8.99B
Revenue (TTM)
$3.99B
P/E
14.92
EPS
4.08
Dividend yield
1.87%
Beta (5Y)
0.19
52-week high
Dkr62.85
52-week low
Dkr35.30
Avg volume (3M)
—
Shares outstanding
991.23M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Sichuan Kelun Pharmaceutical Co., Ltd.SZSE: 002422$10.17BCN¥42.67-1.77%
Haisco Pharmaceutical Group Co., Ltd.SZSE: 002653$9.64BCN¥58.03-1.41%
Lupin LimitedBSE: 500257$9.56BRs1,953.90-0.94%
Eisai Co., Ltd.TSE: 4523$9.29B¥5,240.00-1.06%
Kyowa Kirin Co., Ltd.TSE: 4151$8.39B¥2,552.50-1.05%
Krka, d. d.LJSE: KRKG$8.29B€250.00-0.40%
ALK-Abelló A/SCPSE: ALK B$8.14BDkr248.40-0.16%
Glenmark Pharmaceuticals LimitedNSEI: GLENMARK$7.88BRs2,608.50-1.42%

Browse every Pharmaceuticals company →